Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-15 1:09 pm Sale | 13G | Cidara Therapeutics Inc. CDTX | LYTTON LAURENCE W | 1,708,328 2.5% | -1,632,072 (-48.86%) | View |
| 2022-02-14 7:50 pm Sale | 13G | DUOS TECHNOLOGIES GROUP INC. DUOT | LYTTON LAURENCE W | 214,700 5.9% | -1,000 (-0.46%) | View |
| 2022-02-14 7:45 pm Purchase | 13G | GRESHAM WORLDWIDE INC. GIGA | LYTTON LAURENCE W | 274,951 9.99% | 27,251 (+11.00%) | View |
| 2022-02-14 7:44 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 4,177,792 6.6% | -566,211 (-11.94%) | View |
| 2021-12-30 12:27 pm Purchase | 13G | LIQTECH INTL INC PAR $0.00 LIQT | LYTTON LAURENCE W | 2,209,974 10.4% | 287,789 (+14.97%) | View |
| 2021-10-06 4:19 pm Purchase | 13G | DIAMEDICA THERAPEUTI DMAC | LYTTON LAURENCE W | 1,380,266 5.2% | 1,380,266 (New Position) | View |
| 2021-03-05 7:26 pm Purchase | 13G | Cidara Therapeutics Inc. CDTX | LYTTON LAURENCE W | 3,340,400 7% | 613,328 (+22.49%) | View |
| 2021-03-05 4:55 pm Purchase | 13G | Cidara Therapeutics Inc. CDTX | LYTTON LAURENCE W | 2,727,072 5.7% | 2,727,072 (New Position) | View |
| 2021-02-16 12:24 pm Sale | 13G | CHEMBIO DIAGNOSTICS, INC. CEMI | LYTTON LAURENCE W | 0 0% | -1,010,718 (Position Closed) | View |
| 2021-02-16 11:46 am Purchase | 13G | Vertex Energy, Inc VTNR | LYTTON LAURENCE W | 4,093,561 9% | 1,374,473 (+50.55%) | View |
| 2021-02-16 11:43 am Purchase | 13G | Catheter Precision Inc. VTAK | LYTTON LAURENCE W | 240,952 7.7% | 240,952 (New Position) | View |
| 2021-02-16 11:39 am Sale | 13G | LIQTECH INTL INC PAR $0.00 LIQT | LYTTON LAURENCE W | 1,922,185 8.7% | -255,702 (-11.74%) | View |
| 2021-02-16 11:37 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | LYTTON LAURENCE W | 484,412 9.99% | 484,412 (New Position) | View |
| 2021-02-16 11:34 am Purchase | 13G | GRESHAM WORLDWIDE INC. GIGA | LYTTON LAURENCE W | 247,700 9.4% | 1,900 (+0.77%) | View |
| 2021-02-16 11:32 am Sale | 13G | EMCORE CORP EMKR | LYTTON LAURENCE W | 1,718,303 5.8% | -1,040,575 (-37.72%) | View |
| 2021-02-16 11:30 am Sale | 13G | DUOS TECHNOLOGIES GROUP INC. DUOT | LYTTON LAURENCE W | 215,700 6.1% | -67,300 (-23.78%) | View |
| 2021-02-16 11:26 am Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 4,744,003 9.99% | 2,341,382 (+97.45%) | View |
| 2021-02-16 11:22 am Sale | 13G | Apollo Endosurgery Inc. APEN | LYTTON LAURENCE W | 2,648,150 9.99% | -17,782 (-0.67%) | View |
| 2021-01-04 12:35 pm Purchase | 13G | Viracta Therapeutics Inc. VIRX | LYTTON LAURENCE W | 1,598,519 8.8% | 1,598,519 (New Position) | View |
| 2020-06-12 4:09 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 2,402,621 9.99% | 2,402,621 (New Position) | View |